Skip to main content
. 2021 Oct 1;21:473. doi: 10.1186/s12872-021-02287-w

Table 2.

Postoperative data of the patients

TMZ
(n = 40)
Placebo
(n = 40)
P
Delirium, n (%) 4 (10.0) 5 (12.5) 0.15
Incidence of postoperative nausea and vomiting, n (%) 5 (12.5) 6 (15.0) 0.45
ICU stay, hours, Mean (SD) 10 (2) 14 (1) 0.04
In-hospital morbidity and mortality, n (%) 2 (5.0) 1 (2.0) < 0.05
Length of hospital stay, days, Mean (SD) 7 (1) 9 (1) 0.20

TMZ, Trimetazidine; ICU, intensive care unit